Hello RHY shareholders,
Not sure if someone can assist with the following question - I have read a comment on the RHY HC thread that commercialisation of RHY is a long way off. My understanding from the last published "Investor Presentation" is that "Study 7" will have to be completed before the CE Mark submission/ application can be made.
Is there any guidance on when the CE & FDA approval (or application) is planned for?
Enjoy the weekend.
FDV
Ann: Appendix 4C - quarterly, page-2
Add RHY (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.5¢ |
Change
-0.005(3.85%) |
Mkt cap ! $31.07M | |||
| Open | High | Low | Value | Volume |
| 12.5¢ | 12.5¢ | 12.0¢ | $6.822K | 54.92K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8925 | 12.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.0¢ | 7207 | 2 |
View Market Depth
| Last trade - 15.46pm 13/11/2024 (20 minute delay) ? |
| RHY (ASX) Chart |